Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duyen H Pham

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2012
Isoform-selective assays for sphingosine kinase activityMelissa R Pitman, Duyen H Pham, Stuart M Pitson
Biotechniques|August 9, 2008
Attenuation of leakiness in doxycycline-inducible expression via incorporation of 3' AU-rich mRNA destabilizing elementsDuyen H Pham, Paul A B Moretti, Gregory J Goodall, et al.
Molecular Psychiatry|June 13, 2018
A systematic review and meta-analysis of 271 PCDH19-variant individuals identifies psychiatric comorbidities, and association of seizure onset and disease severityKristy L Kolc, Lynette G Sadleir, Ingrid E Scheffer, et al.
Human Molecular Genetics|March 24, 2017
Protocadherin 19 (PCDH19) interacts with paraspeckle protein NONO to co-regulate gene expression with estrogen receptor alpha (ERα)Duyen H Pham, Chuan C Tan, Claire C Homan, et al.
Oncotarget|March 20, 2015
A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer propertiesMelissa R Pitman, Jason A Powell, Carl Coolen, et al.
Oncotarget|September 3, 2016
An oncogenic role for sphingosine kinase 2Heidi A Neubauer, Duyen H Pham, Julia R Zebol, et al.
Human Molecular Genetics|July 1, 2015
Mutations of protocadherin 19 in female epilepsy (PCDH19-FE) lead to allopregnanolone deficiencyChuan Tan, Chloe Shard, Enzo Ranieri, et al.
Human Mutation|June 3, 2021
Integrated in silico and experimental assessment of disease relevance of PCDH19 missense variantsDuyen H Pham, Melissa R Pitman, Raman Kumar, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2012
Isoform-selective assays for sphingosine kinase activityMelissa R Pitman, Duyen H Pham, Stuart M Pitson
Biotechniques|August 9, 2008
Attenuation of leakiness in doxycycline-inducible expression via incorporation of 3' AU-rich mRNA destabilizing elementsDuyen H Pham, Paul A B Moretti, Gregory J Goodall, et al.
Molecular Psychiatry|June 13, 2018
A systematic review and meta-analysis of 271 PCDH19-variant individuals identifies psychiatric comorbidities, and association of seizure onset and disease severityKristy L Kolc, Lynette G Sadleir, Ingrid E Scheffer, et al.
Human Molecular Genetics|March 24, 2017
Protocadherin 19 (PCDH19) interacts with paraspeckle protein NONO to co-regulate gene expression with estrogen receptor alpha (ERα)Duyen H Pham, Chuan C Tan, Claire C Homan, et al.
Oncotarget|March 20, 2015
A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer propertiesMelissa R Pitman, Jason A Powell, Carl Coolen, et al.
Oncotarget|September 3, 2016
An oncogenic role for sphingosine kinase 2Heidi A Neubauer, Duyen H Pham, Julia R Zebol, et al.
Human Molecular Genetics|July 1, 2015
Mutations of protocadherin 19 in female epilepsy (PCDH19-FE) lead to allopregnanolone deficiencyChuan Tan, Chloe Shard, Enzo Ranieri, et al.
Human Mutation|June 3, 2021
Integrated in silico and experimental assessment of disease relevance of PCDH19 missense variantsDuyen H Pham, Melissa R Pitman, Raman Kumar, et al.
Pageof 1